Bispecific antibodies for Research Use

ichorbio has developed a range of bisoecific biosimilars that are specifically for research use only.

• Odronextamab Biosimilar - Research Grade [ICH5027] $350.00 – $9,000.00
• Cibisatamab Biosimilar - Research Grade [ICH5041] $350.00 – $9,000.00
• Glofitamab Biosimilar - Research Grade [ICH5019] $350.00 – $9,000.00
• Blinatumomab Biosimilar - Research Grade [ICH5025] $300.00 – $4,000.00
• Vudalimab Biosimilar - Research Grade [ICH5113] $350.00 – $3,225.00
• Emicizumab Biosimilar - Research Grade [ICH5178] $350.00 – $9,000.00
• Mosunetuzumab Biosimilar - Research Grade [ICH5026] $350.00 – $9,000.00